Invex Therapeutics Ltd.ASX: IXC

Exenatide Meets Key Endpoints in IIH Clinical Trial

May 20, 2020 at 3:54 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment